THE QUALITY-OF-LIFE IN ADULT FEMALE-PATIENTS WITH CONGENITAL ADRENAL-HYPERPLASIA - A COMPREHENSIVE STUDY OF THE IMPACT OF GENITAL MALFORMATIONS AND CHRONIC DISEASE ON FEMALE-PATIENTS LIFE

被引:115
作者
KUHNLE, U [1 ]
BULLINGER, M [1 ]
SCHWARZ, HP [1 ]
机构
[1] UNIV MUNICH,INST MED PSYCHOL,D-80336 MUNICH,GERMANY
关键词
QUALITY OF LIFE; EVALUATION; CONGENITAL ADRENAL HYPERPLASIA; ADULT FEMALE PATIENTS;
D O I
10.1007/BF02276713
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Female patients with congenital adrenal hyperplasia have been frequently studied in order to determine the impact of prenatal androgen exposure on various aspects of psychological, psychosocial and psychosexual development. There is no published study to evaluate the impact of the genital malformation, genital operations and chronic medication on the quality of life in adult females with congenital adrenal hyperplasia. We performed a quality-of-life evaluation in adult female patients with congenital adrenal hyperplasia due to a 21-hydroxylation defect. The patients were asked to fill out questionnaires covering the four domains of health-related quality of life, namely physical state, psychological well-being, social relationships and functional capacity as well as questionnaires covering the areas of psychosexual identification and psychosocial integration. In addition a semistructured interview was performed covering medical history as well as physical, emotional, social and psychosexual development. The results were evaluated using a computerized statistical program for social sciences. Forty-five patients agreed to participate (44 could be interviewed) and their medical data did not differ from the 20 patients (medical data were available from 16 patients) who refused to participate. Median age at diagnosis was below 1 year in 54.8 of the participating patients; range was from 0 to 30 years. Of the participants, 48.6%, 34.2% and 17.2% suffered from the simple-virilizing- salt-wastings- and late-on-set-form of congenital adrenal hyperplasia, respectively. The mean adult height was 157.8 cm, and mean weight was 56.8 kg. In 35.7% the degree of genital virilization was classified as Prader stage 3 or 4. The patients with the salt-wasting form were significantly more virilized at birth than those with the simple-virilizing form resulting in more genital operations and more complications in later life. The patients differed significantly from controls in certain aspects. They were more often single (47.8% vs 66.7%) and had less children (22.2% vs 38.6%). Patients with the salt-wasting form of congenital adrenal hyperplasia also had more problems in establishing heterosexual relationships and conceiving and bearing children. Homosexual preference was not increased. In addition, significant impairments were found with regard to psychosexual. identification, but they were successful in terms of adjustment to illness and in receiving social support. The overall quality of life was not significantly different in patients and controls. Even though the patients suffered from a chronic illness and congenital malformations which significantly disturbed their body image, female identity and psychosexual identification, no effect on the overall quality of life could be detected. The differences found regarding social support and illness processing may be mechanisms which they have developed to enable them to cope. These mechanisms seem to be helpful and necessary to maintain a high level of well-being despite impairment, which is in turn reflected by a high quality of life. Conclusion Adult female patients wth congenital adrenal hyperplasia :seem to be able to adapt well to their impairment and chronic condition. However, problems regarding partnership and sexuality are present and might become more pronounced in later life.
引用
收藏
页码:708 / 716
页数:9
相关论文
共 43 条
[1]  
AARONSON NK, 1987, QUALITY LIFE CANCER
[2]  
[Anonymous], 1971, EITS MANUAL PROFILE
[3]  
APPELT H, 1989, PSYCHONEUROENDOCRINO
[4]   PSYCHOSEXUAL DIFFERENTIATION IN THE HUMAN [J].
BAKER, SW .
BIOLOGY OF REPRODUCTION, 1980, 22 (01) :61-72
[5]  
BECKMANN D, 1975, GIESSEN TEST
[6]  
BULLINGER M, 1991, HEART FAILURE QUALIT, V1, P164
[7]  
Bullinger M, 1988, DTSCH ARZTEBL, V85, P679
[8]  
BULLINGER M, 1991, HOFGREFE HUBER, P91
[9]  
BULLINGER M, 1993, Z MED PSYCHOL, V2, P121
[10]  
BULLINGER M, 1991, CONTROL CLIN TRIALS, V12, P919